Review of PURPOSE Trials Studying Use of…
Updates from the 2024 Conference of the…
Evidence and considerations in PrEP and PEP use
Selected Abstracts from the 2023 CROI Conference
Discussion of use of LAI ART for persons with…
Data on the newly approved medication Lenacapavir
HIV Treatment Guidelines
Injectable ART for those with detectable viral…
Update on long-acting Cabotegravir asPrEP,…
The "how to" of using Cabotegravir/…